Science 37, the platform for accelerating clinical trials, has raised $40M in venture funding from investors that include Lux Capital, Redmile Group, PPD, Novartis, Amgen, Sanofi Ventures, GV, Glynn Capital, LifeSci Ventures, and Mubadala Ventures. Founded by Belinda Tan and Noah Craft in 2014, Science 37 has now raised a total of $147.5M in reported equity funding.
The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (LA Tech, NYC Tech, London Tech, Paris Tech, Boston Tech) TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the Los Angeles business community and beyond. All our digital content has no cancellation risk due to coronavirus or any other health hazards and engagement has been up 43%. Find out how to run a digital campaign that will return your investment here.
